Yong Teng Selected Research

ADP-Ribosylation Factor 1

1/2020	Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma.
2/2019	Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
9/2016	Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Teng Research Topics

Disease

55	Neoplasms (Cancer) 07/2022 - 03/2012
20	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2012
14	Squamous Cell Carcinoma of Head and Neck 02/2022 - 01/2018
11	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2013
9	Carcinogenesis 01/2022 - 04/2014
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2016
5	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 09/2013
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2018
4	Hypoxia (Hypoxemia) 01/2021 - 09/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 03/2019
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 04/2013
2	Mouth Neoplasms (Oral Cancer) 01/2020 - 11/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2013
2	Infections 07/2008 - 03/2002
1	Glioblastoma (Glioblastoma Multiforme) 07/2022
1	Type 2 Diabetes Mellitus (MODY) 07/2022
1	Lymphatic Metastasis 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Rupture 08/2021

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
15	Proteins (Proteins, Gene)FDA Link 08/2021 - 07/2008
7	EnzymesIBA 01/2022 - 11/2015
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
5	Biological ProductsIBA 05/2022 - 01/2019
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019 - 01/2017
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 02/2019
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2022 - 02/2021
3	saracatinibIBA 01/2022 - 01/2018
3	Long Noncoding RNAIBA 10/2021 - 01/2021
3	LigandsIBA 10/2021 - 11/2018
3	CytokinesIBA 08/2021 - 01/2014
3	Therapeutic UsesIBA 01/2021 - 12/2019
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2017
3	ADP-Ribosylation Factor 1IBA 01/2020 - 09/2016
3	Monomeric GTP-Binding ProteinsIBA 02/2019 - 01/2017
3	CYT997IBA 01/2019 - 12/2017
3	Peptides (Polypeptides)IBA 12/2017 - 02/2016
2	CurcuminIBA 07/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2016
2	AgarIBA 01/2022 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 12/2019
2	Superoxides (Superoxide)IBA 01/2022 - 01/2020
2	Histones (Histone)IBA 01/2022 - 02/2019
2	CarbonIBA 01/2022 - 01/2020
2	devimistatIBA 12/2021 - 04/2020
2	Oxidoreductases (Dehydrogenase)IBA 12/2021 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2021
2	Transcription Factors (Transcription Factor)IBA 08/2021 - 11/2015
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2021 - 09/2013
2	Annexin A5IBA 08/2021 - 01/2017
2	H3B-6527IBA 03/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2021
2	Wiskott-Aldrich Syndrome Protein FamilyIBA 01/2021 - 02/2016
2	AntibodiesIBA 01/2021 - 01/2017
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2018
2	Cathepsin BIBA 01/2020 - 12/2019
2	capivasertibIBA 01/2020 - 12/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 02/2018
2	BLU9931IBA 01/2019 - 11/2018
2	VimentinIBA 01/2019 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2019 - 03/2016
1	protoporphyrin IXIBA 07/2022
1	Photosensitizing Agents (Photosensitizers)IBA 07/2022
1	BiguanidesIBA 07/2022
1	Metformin (Glucophage)FDA LinkGeneric 07/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Tocopherols (Tocopherol)IBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	IonsIBA 01/2022
1	CB-839IBA 12/2021
1	Glutamine (L-Glutamine)FDA Link 12/2021
1	Ketoglutarate Dehydrogenase Complex (Oxoglutarate Dehydrogenase)IBA 12/2021
1	Pyruvic Acid (Pyruvate)IBA 12/2021
1	Drug CarriersIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	PLA-695IBA 10/2021
1	Tamoxifen FDA LinkGeneric 10/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Phospholipases A2 (Phospholipase A2)IBA 10/2021
1	PhosphatidylserinesIBA 08/2021
1	Interleukin-10 (Interleukin 10)IBA 08/2021
1	c-Mer Tyrosine KinaseIBA 08/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2021
1	CalreticulinIBA 08/2021
1	NanoconjugatesIBA 06/2021

Therapy/Procedure

26	Therapeutics 02/2022 - 11/2010
4	Drug Therapy (Chemotherapy) 08/2021 - 01/2019
3	Radiotherapy 07/2022 - 10/2020
2	Immunotherapy 02/2022 - 06/2021
2	Photochemotherapy (Photodynamic Therapy) 06/2021 - 02/2021
1	Electrodes (Electrode) 01/2022
1	Precision Medicine 01/2022
1	Chemoradiotherapy 01/2022